Profil
Elizabeth Woo worked as an Investor Relations Officer at Biogen, Inc. from 1998 to 2009.
She then worked as a Senior Vice President of Investor and Public Relations at Poxel SA. In 2015, she worked as a Senior Vice President of Investor Relations at Flex Pharma, Inc. Ms. Woo received her undergraduate degree from the University of California, Berkeley and her MBA from Kellogg School of Management.
Anciens postes connus de Elizabeth Woo
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | - |
| POXEL | Investor Relations Contact | - |
Flex Pharma, Inc.
 Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | Investor Relations Contact | - |
Formation de Elizabeth Woo
| University of California, Berkeley | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| POXEL | Health Technology |
| Entreprise privées | 1 |
|---|---|
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | Health Technology |
